Potential Partners

At Mundipharma EDO we are keen to expand our portfolio and further our ambition to make advances in cancer treatment for patients around the world with rare or relapsed/refractory (difficult-to-treat) cancer.

Mundipharma EDO conducts research with leading academic researchers and clinical specialists worldwide. If you have a potential partnering opportunity or are interested in finding out more, please contact info@edoncology.com

Those interested in discussing potential new compounds or assets should visit Mundipharma International in the first instance.